Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Cited by (1,000)

Items 501–600 of 1,000

1. Manganese-Induced NF-κB Activation and Nitrosative Stress Is Decreased by Estrogen in Juvenile Mice
   Julie A. Moreno, Karin M. Streifel, Kelly A. Sullivan, William H. Hanneman, Ronald B. Tjalkens · 2011 · Toxicological Sciences
2. Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease
   Sandeep Vasant More, Dong‐Kug Choi · 2017 · Nutrients
3. Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson’s Disease via Lysophosphatidic Acid Receptors
   Jong Hee Choi, Minhee Jang, Seikwan Oh, Seung-Yeol Nah, Ik‐Hyun Cho · 2018 · Frontiers in Pharmacology
4. Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro
   Mustafa Taleb Ardah, Madiha Mohieldin Merghani, M. Emdadul Haque · 2019 · Neurochemistry International
5. L ‐3‐hydroxyacyl‐CoA dehydrogenase II protects in a model of Parkinson's disease
   Kim Tieu, Céline Perier, Miquel Vila, Casper S. Caspersen, Hui‐Ping Zhang, Peter Teismann, Vernice R. Jackson-Lewis, David M. Stern, Shi Du Yan, Serge Przedborski · 2004 · Annals of Neurology
6. Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation
   Liyan Hou, Cong Zhang, Ke Wang, Xiaofang Liu, Hongwei Wang, Yuning Che, Fuqiang Sun, Xueying Zhou, Xiulan Zhao, Qingshan Wang · 2017 · Toxicology
7. Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase‐2 via CD40: Relevance to Parkinson's disease
   Tatsusada Okuno, Yuji Nakatsuji, Atsushi Kumanogoh, M. Moriya, Hiroshi Ichinose, Hisae Sumi, Harutoshi Fujimura, Hitoshi Kikutani, Saburo Sakoda · 2005 · Journal of Neuroscience Research
8. Exercise does not protect against MPTP-induced neurotoxicity in BDNF happloinsufficent mice
   Gerecke, Kim M., Jiao, Yun, Pagala, Viswajeeth, Smeyne, Richard J. · 2012 · PLoS ONE
9. Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat
   Barthwal, M.K., Srivastava, N., Dikshit, M. · 2001 · Redox Report
10. Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson’s disease via the prosaposin-GPR37-IL-6 axis
    Qiang Ma, Jin-Lan Tian, Yao Lou, Ran Guo, Xiao-Ru Ma, Jianbin Wu, Jing Yang, Bing-Jie Tang, Shun Li, Mengsheng S. Qiu et al. · 2025 · Cell Reports
11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces microglial nitric oxide production and subsequent rat primary cortical neuron apoptosis through p38/JNK MAPK pathway
    Yuanye Li, Gang Chen, Jianya Zhao, Xiaoke Nie, Chunhua Wan, Jiao Liu, Zhiqing Duan, Guangfei Xu · 2013 · Toxicology
12. A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease
    Chi‐Jing Choong, Tsutomu Sasaki, Hideki Hayakawa, Toru Yasuda, Kousuke Baba, Yoshiyuki Hirata, Shinichi Uesato, Hideki Mochizuki · 2015 · Neurobiology of Aging
13. Ratiometric SERS imaging and selective biosensing of nitric oxide in live cells based on trisoctahedral gold nanostructures
    Qiao Xu, Wei Liu, Li Li, Feng Zhou, Jian Er Zhou, Yang Tian · 2017 · Chemical Communications
14. GYY4137, an H2S Slow-Releasing Donor, Prevents Nitrative Stress and α-Synuclein Nitration in an MPTP Mouse Model of Parkinson’s Disease
    Xiao‐Ou Hou, Yuqing Yuan, Yulan Sheng, Baoshi Yuan, Yali Wang, Jiyue Zheng, Chun‐Feng Liu, Xiaohu Zhang, Li‐Fang Hu · 2017 · Frontiers in Pharmacology
15. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding
    Tomohiro Nakamura, Stuart A. Lipton · 2007 · Cell Death and Differentiation
16. Dietary Polyphenols and Their Effects on Cell Biochemistry and Pathophysiology 2013
    Tullia Maraldi, David Vauzour, Cristina Angeloni · 2014 · Oxidative Medicine and Cellular Longevity
17. Therapeutically targeting astrocytes with stem and progenitor cell transplantation following traumatic spinal cord injury
    Aditi Falnikar, Ke Li, Angelo C. Lepore · 2014 · Brain Research
18. Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats
    Jang-Won Lee, Vı́ctor Tapias, Roberto Di Maio, J. Timothy Greenamyre, Jason R. Cannon · 2014 · Neurobiology of Aging
19. Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice
    Hironori Yokoyama, Sho Takagi, Yu Watanabe, Hiroyuki Kato, Tsutomu Araki · 2008 · Journal of Neural Transmission
20. Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice
    Stephen J. Crocker, Peter Liston, Hymie Anisman, Christopher J. Lee, Patrice D. Smith, N Earl, Charlie S. Thompson, David S. Park, Robert G. Korneluk, George S. Robertson · 2003 · Neurobiology of Disease
21. Strain‐dependent susceptibility to MPTP and MPP‐induced Parkinsonism is determined by glia
    Michelle Smeyne, Olga G. Goloubeva, Richard Jay Smeyne · 2001 · Glia
22. The Neuroprotective Effect of Fisetin in the MPTP Model of Parkinson's Disease
    Mital Y. Patel, Hirenkumar Panchal, Othman Ghribi, Kenza E. Benzeroual · 2012 · Journal of Parkinson s Disease
23. Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease
    Angélique Virgone‐Carlotta, Josselin Uhlrich, Muhammad Numan Akram, Denis Ressnikoff, Fabrice Chrétien, Chantal Domenget, Romain Kroum Gherardi, Geneviève Despars, Pierre Jurdic, Jérôme Honnorat et al. · 2013 · Glia
24. Exacerbation of Dopaminergic Terminal Damage in a Mouse Model of Parkinson’s Disease by the G-Protein-Coupled Receptor Protease-Activated Receptor 1
    Cecily E. Hamill, William Michael Caudle, Jason R. Richardson, Hongjie Yuan, Kurt D. Pennell, James G. Greene, Gary Wright Miller, Stephen F. Traynelis · 2007 · Molecular Pharmacology
25. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence
    Carmen Avagliano, Roberto Russo, Carmen De Caro, Claudia Cristiano, Giovanna La Rana, Giuseppe Piegari, Orlando Paciello, Rita Citraro, Emilio Russo, Giovambattista De Sarro et al. · 2016 · Pharmacological Research
26. Role of Molecular Hydrogen in Ageing and Ageing‐Related Diseases
    Zhiling Fu, Jin Zhang, Yan Zhang · 2022 · Oxidative Medicine and Cellular Longevity
27. NADPH Oxidase and the Degeneration of Dopaminergic Neurons in Parkinsonian Mice
    Marina S. Hernandes, Cecília C. Café-Mendes, Luiz Roberto Britto · 2013 · Oxidative Medicine and Cellular Longevity
28. Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
    Anna Rosa Carta, Augusta Pisanu, Ezio Carboni · 2011 · Parkinson s Disease
29. Novel Para-Phenyl Substituted Diindolylmethanes Protect Against MPTP Neurotoxicity and Suppress Glial Activation in a Mouse Model of Parkinson’s Disease
    Briana R. De Miranda, Katriana A. Popichak, Sean L. Hammond, James Adam Miller, Stephen H Safe, Ronald B. Tjalkens · 2014 · Toxicological Sciences
30. Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease
    Lucian Hriţcu, Alin Stelian Ciobica, Marius Ștefan, Marius Mihăşan, Lavinia Palamiuc, Toshitaka Nabeshima · 2011 · Neuroscience Research
31. Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures
    Santiago Canals, Marı́a José Casarejos, Eulalia Rodríguez‐Martín, Sonsoles de Bernardo, M. A. Mena · 2001 · Journal of Neurochemistry
32. Developing electrochemical sensor for point-of-care diagnostics of oxidative stress marker using imprinted bimetallic Fe/Pd nanoparticle
    Ekta Roy, Santanu Patra, Rashmi Madhuri, Prashant K. Sharma · 2014 · Talanta
33. Neuroprotective and Neurotherapeutic Effects of Tetrahedral Framework Nucleic Acids on Parkinson’s Disease in Vitro
    Weitong Cui, Yuxi Zhan, Xiaoru Shao, Wei Fu, Dexuan Xiao, Junyao Zhu, Xin Qin, Tianyi Zhang, Mei Zhang, Yi Zhou et al. · 2019 · ACS Applied Materials & Interfaces
34. Neuroprotective and Neurorescue Mode of Action of Bacopa monnieri (L.) Wettst in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease: An In Silico and In Vivo Study
    Babita Singh, Shivani Pandey, Mohammad Rumman, Shashank Kumar, Prem Prakash Kushwaha, Rajesh Verma, Abbas Ali Mahdi · 2021 · Frontiers in Pharmacology
35. The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity
    Mélissa Côté, Janelle Drouin‐Ouellet, Francesca Cicchetti, Denis Soulet · 2011 · Brain Behavior and Immunity
36. Mangiferin Antagonizes Rotenone: Induced Apoptosis Through Attenuating Mitochondrial Dysfunction and Oxidative Stress in SK-N-SH Neuroblastoma Cells
    Kavitha, Mani, Manivasagam, Thamilarasan, Essa, Musthafa Mohamed, Tamilselvam, Kuppusamy, Selvakumar, Govindasamy Pushpavathy, Karthikeyan, Subran, Thenmozhi, Justin Arokiasamy, Subash, Selvaraju · 2014 · Neurochemical Research
37. Peptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson’s disease
    Balachandran Krishnamma Binukumar, Varsha Shukla, Niranjana D. Amin, Philip G. Grant, M. Bhaskar, Susan Skuntz, Joseph P. Steiner, Harish C. Pant · 2015 · Molecular Biology of the Cell
38. Differential Protein Distribution between the Nucleus and Mitochondria: Implications in Aging
    Eirini Lionaki, Ilias Gkikas, Nektarios Tavernarakis · 2016 · Frontiers in Genetics
39. Brain-derived neurotropic factor and GABAergic transmission in neurodegeneration and neuroregeneration
    Miyoung Yang, Changjong Moon, Jinwook Kim, Sueun Lee, Sohi Kang, Sung‐Ho Kim, Jong-Choon Kim · 2017 · Neural Regeneration Research
40. Demethoxycurcumin, a natural derivative of curcumin abrogates rotenone-induced dopamine depletion and motor deficits by its antioxidative and anti-inflammatory properties in Parkinsonian rats
    Srinivasagam Rajasankar, Muthu Ramkumar, Veerapan Venkatesh Gobi, Udaiyappan Janakiraman, Thamilarasan Manivasagam, Arokiasamy Justin Thenmozhi, Musthafa Mohamed Essa, Ranganathan Chidambaram, Saravana Babu Chidambaram, Gilles J. Guillemin · 2018 · Pharmacognosy Magazine
41. The unlikely partnership between LRRK 2 and α‐synuclein in Parkinson's disease
    Noémie Cresto, Camille Gardier, Francesco Gubinelli, Marie‐Claude Gaillard, Géraldine Liot, West Andrew B, Emmanuel Brouillet · 2018 · European Journal of Neuroscience
42. Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression
    Victor C. Huber, Tapan Kumar Mondal, Stewart Alan Factor, Richard F. Seegal, David A. Lawrence · 2006 · Journal of Neuroinflammation
43. A cytokine mixture of GM‐CSF and IL‐3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6‐OHDA)‐induced Parkinsonism of rats
    Mohammed Emamussalehin Choudhury, Kana Sugimoto, Madoka Kubo, Masahiro Nagai, Masahiro Nomoto, Hisaaki Takahashi, Hajime Yano, Junya Tanaka · 2011 · Brain and Behavior
44. In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole
    Bobby Thomas, Karuppagounder S. Saravanan, Kochupurackal P. Mohanakumar · 2007 · Neurochemistry International
45. Nitric Oxide Donors Induce Neurotrophin-Like Survival Signaling and Protect Neurons against Apoptosis
    Carsten Culmsee, Norbert Gerling, Stefan Landshamer, Bianca Rickerts, Hans‐Jürgen Duchstein, Kazuo Umezawa, Susanne Klumpp, Josef Krieglstein · 2005 · Molecular Pharmacology
46. Silibinin Attenuates MPP + -Induced Neurotoxicity in the Substantia Nigra In Vivo
    Un Ju Jung, Min‐Tae Jeon, Myung‐Sook Choi, Sang Ryong Kim · 2014 · Journal of Medicinal Food
47. Neuroprotection by Silencing iNOS Expression in a 6-OHDA Model of Parkinson’s Disease
    Min Li, Fu-rong Dai, Xiaoping Du, Qidong Yang, Yuxiang Chen · 2012 · Journal of Molecular Neuroscience
48. Pathological consequences of inducible nitric oxide synthase expression in hippocampal slice cultures
    Sophie Duport, John Garthwaite · 2005 · Neuroscience
49. Involvement of dopaminergic neuronal cystatin C in neuronal injury‐induced microglial activation and neurotoxicity
    Garima Dutta, David S. Barber, Ping Zhang, Nicholas J. Doperalski, Bin Liu · 2012 · Journal of Neurochemistry
50. Role of Nitric Oxide in Motor Control: Implications for Parkinson's Disease Pathophysiology and Treatment
    Elaine Del-Bel, Fernando E. Padovan‐Neto, Rita Raisman‐Vozari, Márcio Lazzarini · 2011 · Current Pharmaceutical Design
51. Effect of Microglia Activation on Dopaminergic Neuronal Injury Induced by Manganese, and Its Possible Mechanism
    Mingchao Liu, Tongjian Cai, Fang Zhao, Gang Zheng, Qiang Wang, Yaoming Chen, Chuanshu Huang, Wenjing Luo, Jingyuan Chen · 2009 · Neurotoxicity Research
52. Attenuation of MPTP/MPP+ toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin
    Huiling Gao, C. Li, Hiroaki Nabeka, Tetsuya Shimokawa, Shouichiro Saito, Zhan‐You Wang, Yaming Cao, Seiji Matsuda · 2013 · Neuroscience
53. GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment
    Julieta Mendes‐Oliveira, Filipa Lopes Campos, Rita Alexandra Videira, Graça Baltazar · 2017 · Brain Behavior and Immunity
54. Recombinant human granulocyte colony‐stimulating factor protects against MPTP‐induced dopaminergic cell death in mice by altering Bcl‐2/Bax expression levels
    Xuqing Cao, Hiroyuki Arai, Yong‐Ri Ren, Hideki Oizumi, Ning Zhang, Shiho Seike, Tsuyoshi Furuya, Toru Yasuda, Yoshikuni Mizuno, Hideki Mochizuki · 2006 · Journal of Neurochemistry
55. Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP
    Andis Klegeris, Patrick L. McGeer · 2003 · Journal of Leukocyte Biology
56. Melatonin attenuated mediators of neuroinflammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat astrocytoma cells, C6
    Rituraj Niranjan, Chandishwar Nath, Rakesh Shukla · 2012 · Free Radical Research
57. 1H MRS identifies lactate rise in the striatum of MPTP‐treated C57BL/6 mice
    Keiko Koga, Atsushi Mori, Satoshi Ohashi, Naoki Kurihara, Hisashi Kitagawa, Makoto Ishikawa, Yasuhide Mitsumoto, Masami Nakai · 2006 · European Journal of Neuroscience
58. Discovery of a Natural Product-Like iNOS Inhibitor by Molecular Docking with Potential Neuroprotective Effects In Vivo
    Hai‐Jing Zhong, Lijuan Liu, Cheong‐Meng Chong, Lihua Lu, Modi Wang, Daniel Shiu‐Hin Chan, Philip Wai Hong Chan, Simon Ming‐Yuen Lee, Dik‐Lung Ma, Chung‐Hang Leung · 2014 · PLoS ONE
59. Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro
    Teresa Iuvone, Giuseppe Esposito, Daniele De Filippis, Tiziana Bisogno, Stefania Petrosino, Caterina Scuderi, Vincenzo Di Marzo, Luca Steardo · 2007 · Journal of Molecular Medicine
60. STAT1 Mediates Oroxylin A Inhibition of iNOS and Pro-Inflammatory Cytokines Expression in Microglial BV-2 Cells
    Po-Wen Liu, Meifang Chen, Andy Po‐Yi Tsai, Tony J.-F. Lee · 2012 · PLoS ONE
61. Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice
    Gao, Liang, Brenner, David, Llorens-Bobadilla, Enric, Saiz-Castro, Gonzalo, Frank, Tobias, Wieghofer, Peter, Hill, Oliver, Thiemann, Meinolf, Karray, Saoussen, Prinz, Marco et al. · 2015 · Journal of Experimental Medicine
62. Enhanced Astrocytic Nitric Oxide Production and Neuronal Modifications in the Neocortex of a NOS2 Mutant Mouse
    Yossi Buskila, Yasmin Abu‐Ghanem, Yifat Levi, Arie Moran, Ettie Grauer, Yael Amitai · 2007 · PLoS ONE
63. Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA Parkinsonian model is associated with inhibition of microglial activation and MMP expression
    Mona Sadeghian, Lilia Marinova-Mutafchieva, Lauren Broom, Janet L. Davis, David J. Virley, Andrew D. Medhurst, David Trevor Dexter · 2012 · Journal of Neuroimmunology
64. The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6
    Rituraj Niranjan, Chandishwar Nath, Rakesh Shukla · 2010 · Free Radical Research
65. Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease
    Carmen Noelker, Lydie J. Morel, Anke Osterloh, Daniel Alvarez‐Fischer, Thomas Lescot, Minka Breloer, Maike Gold, Wolfgang Hermann Oertel, Carmen Henze, Patrick Pierre Michel et al. · 2014 · Journal of Neuroinflammation
66. Aquaporin 4: A key player in Parkinson's disease
    Omid Reza Tamtaji, Mohammad Behnam, Mohammad Ali Pourattar, Hamed Jafarpour, Zatollah Asemi · 2019 · Journal of Cellular Physiology
67. Therapeutic Effect of Modulating TREM-1 via Anti-inflammation and Autophagy in Parkinson’s Disease
    Chien‐Wei Feng, Nan‐Fu Chen, Chun‐Sung Sung, Hsiao‐Mei Kuo, San‐Nan Yang, Chien‐Liang Chen, Han-Chun Hung, Bing‐Hung Chen, Zhi‐Hong Wen, Wu-Fu Chen · 2019 · Frontiers in Neuroscience
68. Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease
    Candan Depboylu, Kathrin Schorlemmer, Martin Klietz, Wolfgang Hermann Oertel, Eberhard Weihe, Günter U. Höglinger, Martin K.-H. Schäfer · 2011 · Journal of Neuroimmunology
69. Coinduction of inducible nitric oxide synthase and arginine recycling enzymes in cytokine-stimulated PC12 cells and high output production of nitric oxide
    Wen Yi Zhang, Tomomi Gotoh, Seiichi Oyadomari, Masataka Mori · 2000 · Molecular Brain Research
70. Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease
    Suraj Pradhan, Katrin I. Andreasson · 2012 · Experimental Neurology
71. Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation
    Kim, Sang Ryong, Chung, Eun Sook, Bok, Eugene, Baik, Hyung Hwan, Chung, Young Cheul, Won, So Yoon, Joe, Eunhye, Kim, Tae Hyong, Kim, Soung Soo, Jin, Min Young et al. · 2010 · Journal of Neuroscience Research
72. Fish oil, melatonin and vitamin E attenuates midbrain cyclooxygenase-2 activity and oxidative stress after the administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine
    Genaro Gabriel Ortíz, Fermín Paúl Pacheco-Moisés, Víctor M. Gómez-Rodríguez, Erika Daniela González-Renovato, Erandis D. Torres-Sánchez, Ana Cristina Ramírez Anguiano · 2013 · Metabolic Brain Disease
73. Oxidative and nitrosative stress in serum of patients with Parkinson’s disease
    Hikmet Can Çubukçu, Mustafa Yurtdaş, İlker Durak, Bilal Aytaç, Hafize Nalan Güneş, Burcu Gökçe Çokal, Tahir Kurtuluş Yoldaş, İlker Durak · 2016 · Neurological Sciences
74. Astroglial DJ-1 over-expression up-regulates proteins involved in redox regulation and is neuroprotective in vivo
    Ann Kristin Frøyset, Amanda J. Edson, Naouel Gharbi, Essa Ahsan Khan, Daniel Christiaan Dondorp, Qing Bai, Ettore Tiraboschi, Maximiliano L. Suster, Joanne B. Connolly, Edward A. Burton et al. · 2018 · Redox Biology
75. GardeninA confers neuroprotection against environmental toxin in a Drosophila model of Parkinson’s disease
    Urmila Maitra, Thomas Harding, Qiaoli Liang, Lukasz M. Ciesla · 2021 · Communications Biology
76. Mouse models of α-synucleinopathy and Lewy pathology
    Bernd Sommer, Samuel Barbieri, Katja Hofele, Karl‐Heinz Wiederhold, A. Probst, Claudia Mistl, Simone Danner, S Kauffmann, Will P. J. M. Spooren, Markus Tolnay et al. · 2000 · Experimental Gerontology
77. Tumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease
    Andreas Leng, Anna Mura, Joram Feldon, Boris Ferger · 2004 · Neuroscience Letters
78. Role of nitric oxide synthase against MPTP neurotoxicity in mice
    R. Kurosaki, Y. Muramatsu, Mari Michimata, Mitsunobu Matsubara, Hisanori Kato, Y. Imai, Yasuto Itoyama, Tsutomu Araki · 2002 · Neurological Research
79. Development of an electrochemical sensor for nitric oxide based on carbon paste electrode modified with Nafion, gold nanoparticles and graphene nanoribbons
    Nadine Wenninger, Urška Bračič, Alexander Kollau, Kingkan Pungjunun, Gerd Leitinger, Kurt Kalcher, Astrid Ortner · 2021 · Sensors and Actuators B Chemical
80. Curcumin Protects Nigrostriatal Dopaminergic Neurons and Reduces Glial Activation in 6-Hydroxydopamine Hemiparkinsonian Mice Model
    Wanida Tripanichkul, Em-orn Jaroensuppaperch · 2011 · International Journal of Neuroscience
81. Adenosine receptors in neurological disorders
    Francesco Impagnatiello, Elena Bastia, Ennio Ongini, Angela Monopoli · 2000 · Emerging Therapeutic Targets
82. α‐synuclein oligomers enhance astrocyte‐induced synapse formation through TGF‐β1 signaling in a Parkinson's disease model
    Luan Pereira Diniz, Isadora C. Pereira Matias, Ana Paula Bérgamo Araújo, Matheus Nunes Garcia, Fernanda G. Q. Barros‐Aragão, Soniza Vieira Alves‐Leon, Jorge Marcondes de Souza, Débora Foguel, Cláudia Pinto Figueiredo, Carolina Alvares da Cunha de Azeredo Braga et al. · 2019 · Journal of Neurochemistry
83. Nuclear factor kappa-B mediates selective induction of neuronal nitric oxide synthase in astrocytes during low-level inflammatory stimulation with MPTP
    David L. Carbone, Julie A. Moreno, Ronald B. Tjalkens · 2008 · Brain Research
84. Characterization and comparative analysis of a new mouse microglial cell model for studying neuroinflammatory mechanisms during neurotoxic insults
    Souvarish Sarkar, Emir Malovic, Deeksha Sarda, Vivek Lawana, Dharmin Rokad, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, Anumantha G. Kanthasamy · 2018 · NeuroToxicology
85. Selective Neuronal Death in Neurodegenerative Diseases: The Ongoing Mystery.
    Srinivasa Subramaniam · 2019 · Europe PMC (PubMed Central)
86. A two-photon ratiometric fluorescent probe for real-time imaging and quantification of NO in neural stem cells during activation regulation
    Mengyu Liang, Zhichao Liu, Zhonghui Zhang, Yuxiao Mei, Yang Tian · 2022 · Chemical Science
87. A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: Pharmacological validation with R-(−)-deprenyl
    Leann P. Quinn, M.J. Perren, Kim T. Brackenborough, P.L. Woodhams, Martin Vidgeon-Hart, Helen Chapman, Menelas N. Pangalos, Neil Upton, David J. Virley · 2007 · Journal of Neuroscience Methods
88. PSMC5 Regulates Microglial Polarization and Activation in LPS-Induced Cognitive Deficits and Motor Impairments by Interacting with TLR4
    Bi, Wei, Bao, Keyao, Zhou, Xinqi, Deng, Yihui, Li, Xiaoting, Zhang, Jiawei, Lan, Xin, Zhao, Jiayi, Lu, Daxiang, Xu, Yezi et al. · 2023 · Journal of Neuroinflammation
89. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
    Janelle Drouin‐Ouellet, Claire Gibrat, M. Bousquet, Frédéric Calon, Jasna Križ, Francesca Cicchetti · 2011 · Journal of Neuroinflammation
90. Arbutin attenuates behavioral impairment and oxidative stress in an animal model of Parkinson's disease.
    Masoumeh Dadgar, Mahdi Pouramir, Zohreh Dastan, Maryam Ghasemi‐Kasman, Manouchehr Ashrafpour, Ali Akbar Moghadamnia, Soraya Khafri, Mohsen Pourghasem · 2018 · Europe PMC (PubMed Central)
91. 3,4-Dihydroxyphenylacetic acid (DOPAC) modulates the toxicity induced by nitric oxide in PC-12 cells via mitochondrial dysfunctioning
    Carla Nunes, Leonor M. Almeida, João A.N. Laranjinha · 2008 · NeuroToxicology
92. Switching the Microglial Harmful Phenotype Promotes Lifelong Restoration of Subtantia Nigra Dopaminergic Neurons from Inflammatory Neurodegeneration in Aged Mice
    Francesca L’Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C. Morale, Francesco Impagnatiello, Bianca Marchetti · 2011 · Rejuvenation Research
93. Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats
    Kazuhiro Takuma, Tatsunori Tanaka, Tsuyoshi Takahashi, Naoki Hiramatsu, Yuki Ota, Yukio Ago, Toshio Matsuda · 2012 · European Journal of Pharmacology
94. trans ‐Cinnamaldehyde Inhibits Microglial Activation and Improves Neuronal Survival against Neuroinflammation in BV2 Microglial Cells with Lipopolysaccharide Stimulation
    Yan Fu, Pin Yang, Yang Zhao, Liqing Zhang, Zhangang Zhang, Xianwen Dong, Zhongping Wu, Ying Xu, Yongjun Chen · 2017 · Evidence-based Complementary and Alternative Medicine
95. Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein
    Na Li, Tessandra Stewart, Lifu Sheng, Min Yan Shi, Eugene M. Cilento, Yufeng Wu, Jau-Syong Hong, Jing Zhang · 2020 · Journal of Neuroinflammation
96. Glial Cell Response: A Pathogenic Factor in Parkinson's Disease
    Du Chu Wu, Kim Tieu, Oren S. Cohen, Dong‐Kug Choi, Miquel Vila, Vernice R. Jackson-Lewis, Peter Teismann, Serge Przedborski · 2002 · Journal of NeuroVirology
97. Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases
    Ana López, Francisco Ortiz, Carolina Doerrier, Carmen Venegas, Marisol Fernández‐Ortiz, Paula Aranda‐Martínez, María Elena Díaz-Casado, Beatriz I. Fernández-Gil, Eliana Barriocanal‐Casado, Germaine Escames et al. · 2017 · PLoS ONE
98. Nitric oxide‐producing microglia mediate thrombin‐induced degeneration of dopaminergic neurons in rat midbrain slice culture
    Hiroshi Katsuki, Mitsugi Okawara, Haruki Shibata, Toshiaki Kume, Akinori Akaike · 2006 · Journal of Neurochemistry
99. Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity
    Bin Xing, Tao Xin, Lingling Zhao, Randy L. Hunter, Yan Chen, Guoying Bing · 2010 · Journal of Neuroimmunology
100. Parasitic manipulation and neuroinflammation: Evidence from the system Microphallus papillorobustus (Trematoda) - Gammarus (Crustacea)
     Simone Helluy, Frédéric Thomas A · 2010 · Parasites & Vectors